Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes

Guy Jerusalem, Andree Rorive, Joelle Collignon Medical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium Abstract: Many systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth fa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jerusalem G, Rorive A, Collignon J
Format: article
Langue:EN
Publié: Dove Medical Press 2014
Sujets:
Accès en ligne:https://doaj.org/article/1f0e58e98d5e486282c90ca33f82886e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!